Amicus Therapeutics (FOLD) Research & Development (2016 - 2025)
Historic Research & Development for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to $23.4 million.
- Amicus Therapeutics' Research & Development fell 1049.31% to $23.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.3 million, marking a year-over-year increase of 2459.79%. This contributed to the annual value of $109.4 million for FY2024, which is 2823.12% down from last year.
- Amicus Therapeutics' Research & Development amounted to $23.4 million in Q3 2025, which was down 1049.31% from $60.8 million recorded in Q2 2025.
- Over the past 5 years, Amicus Therapeutics' Research & Development peaked at $85.6 million during Q4 2021, and registered a low of $23.4 million during Q3 2025.
- Moreover, its 5-year median value for Research & Development was $41.5 million (2023), whereas its average is $48.6 million.
- In the last 5 years, Amicus Therapeutics' Research & Development plummeted by 5512.07% in 2023 and then skyrocketed by 14651.78% in 2025.
- Quarter analysis of 5 years shows Amicus Therapeutics' Research & Development stood at $85.6 million in 2021, then decreased by 25.38% to $63.9 million in 2022, then plummeted by 45.16% to $35.0 million in 2023, then dropped by 13.81% to $30.2 million in 2024, then decreased by 22.44% to $23.4 million in 2025.
- Its Research & Development stands at $23.4 million for Q3 2025, versus $60.8 million for Q2 2025 and $27.8 million for Q1 2025.